Loading financials from SEC filings…
Household & personal products · Consumer Defensive · Fiscal year ends Jun 30
COTY reported revenue of $5.8B in the fiscal year ended Jun 2026, down 1.5% from the year before. Operating income was −$82M, an operating margin of −1.4%, and net income was −$605M. Operating cash flow of $538M less capital expenditure of $190M left free cash flow of $348M. Net debt was $2.9B.
Ranks among the 12 household & personal products companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 5,304 | 5,554 | 6,118 | 5,893 | 5,807 |
| Cost of revenue | 1,935 | 2,007 | 2,179 | 2,072 | 2,155 |
| Gross profit | 3,369 | 3,547 | 3,939 | 3,821 | 3,652 |
| Research & development | 97.3 | 105 | 127 | 123 | 121 |
| Selling, general & admin | 2,881 | 2,818 | 3,162 | 3,103 | 3,108 |
| Operating income | 241 | 544 | 547 | 241 | −81.5 |
| Net interest incomeBanks | −224 | −258 | – | – | – |
| Interest expense | 241 | 261 | 252 | 227 | 184 |
| Pre-tax income | 427 | 705 | 205 | −345 | −610 |
| Income tax | 165 | 182 | 95.1 | 5.4 | −20.0 |
| Net income | 260 | 508 | 89.4 | −368 | −605 |
| Diluted EPS | 0.08 | 0.57 | 0.09 | −0.44 | −0.70 |
| Diluted shares | 834 | 887 | 883 | 871 | 877 |
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Cash & equivalents | 233 | 247 | 301 | 257 | 176 |
| Receivables | 365 | 361 | 442 | 526 | 526 |
| Inventory | 662 | 853 | 764 | 795 | 839 |
| Current assets | 1,682 | 2,052 | 1,964 | 1,953 | 1,918 |
| Net PP&E | 716 | 713 | 719 | 709 | 650 |
| Goodwill | 3,915 | 3,988 | 3,906 | 4,062 | 3,810 |
| Total assets | 12,116 | 12,662 | 12,083 | 11,908 | 10,200 |
| Payables | 1,268 | 1,445 | 1,406 | 1,890 | 1,875 |
| Deferred revenue | 21.5 | 6.9 | 7.5 | – | – |
| Current liabilities | 2,566 | 2,737 | 2,602 | 2,538 | 2,541 |
| Short-term debt | 23.0 | 57.9 | 3.0 | 3.5 | 14.4 |
| Long-term debt | 4,409 | 4,178 | 3,842 | 3,956 | 3,033 |
| Total liabilities | 8,558 | 8,428 | 7,835 | 7,952 | 6,821 |
| Shareholders' equity | 3,155 | 3,811 | 3,827 | 3,543 | 2,990 |
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Operating cash flow | 727 | 626 | 615 | 493 | 538 |
| Capital expenditure | 174 | 223 | 245 | 215 | 190 |
| Free cash flow | 553 | 403 | 369 | 278 | 348 |
| Depreciation & amortisation | 516 | 427 | 421 | 420 | 482 |
| Stock-based compensation | 196 | 136 | 88.8 | 50.0 | 46.3 |
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 4.7% | 10.2% | −3.7% | −1.5% |
| Operating income growth (YoY) | – | 125.7% | 0.6% | −55.9% | −133.8% |
| EPS growth (YoY) | – | 612.5% | −84.2% | −588.9% | – |
| Gross margin | 63.5% | 63.9% | 64.4% | 64.8% | 62.9% |
| Operating margin | 4.5% | 9.8% | 8.9% | 4.1% | −1.4% |
| Net margin | 4.9% | 9.1% | 1.5% | −6.2% | −10.4% |
| Return on equityBlank when equity is negative | 8.2% | 13.3% | 2.3% | −10.4% | −20.2% |
| ROCEEBIT ÷ (assets − current liabilities) | 2.5% | 5.5% | 5.8% | 2.6% | −1.1% |
| Free cash flow margin | 10.4% | 7.3% | 6.0% | 4.7% | 6.0% |
| Cash conversion (CFO ÷ net income) | 2.80x | 1.23x | 6.87x | −1.34x | −0.89x |
| Receivable days | 25 | 24 | 26 | 33 | 33 |
| Inventory days | 125 | 155 | 128 | 140 | 142 |
| Payable days | 239 | 263 | 235 | 333 | 318 |
| Interest cover | 1.00x | 2.08x | 2.17x | 1.06x | −0.44x |
| Debt ÷ equity | 1.41x | 1.11x | 1.00x | 1.12x | 1.02x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | 4,199 | 3,989 | 3,544 | 3,702 | 2,872 |
| Current ratio | 0.66x | 0.75x | 0.75x | 0.77x | 0.75x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.